← Leaderboards
Alan R. Shuldiner
University Of Maryland Baltimore
$66,143,496
Attributed
$68,529,623
Total exposure
26
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.6M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$84,268,632 · 28
By mechanism
U01$40,119,409 · 5
R01$14,844,744 · 5
K12$13,285,225 · 1
P30$11,786,383 · 6
S10$2,088,270 · 2
UH2$1,274,737 · 1
Top collaborators
- Oscar R Benavente3 shared
- Julie A. Johnson3 shared
- Claire M Fraser-Liggett2 shared
- Toni I. Pollin2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Andrew P Goldberg$12,955,492
- Owen R White$64,733,266
- Jay Steven Magaziner$43,042,435
- Simeon I Taylor$9,588,026
- Braxton D Mitchell$18,150,115
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchPhenotypeGeneticGenotypeHuman SubjectGenomicsResearch PersonnelBaseMolecular GeneticsGenesMennoniteResponseObesityCollaborationsVariation (Genetics)Family GeneticsFundingDiabetes Mellitus GeneticsAffectGene ExpressionAmishVariantMemberSampling
Grant awards (113)
Genomics Core$69,511
P30 · FY2016 · NR · contact PI
Genomics Core$67,426
P30 · FY2015 · NR · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes (Administrative Supplment)$41,923
U01 · FY2015 · HG
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$2,690,282
U01 · FY2014 · HL · contact PI
Mid-Atlantic Nutrition Obesity Research Center$1,127,514
P30 · FY2014 · DK · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes$749,344
U01 · FY2014 · HG
Administrative Core$186,643
P30 · FY2014 · DK · contact PI
Research Base$133,145
P30 · FY2014 · DK · contact PI
Genomics Core$67,916
P30 · FY2014 · NR · contact PI
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$2,274,061
U01 · FY2013 · HL · contact PI
Integrated Hamilton Storage System to Support the UMBioBank$1,603,270
S10 · FY2013 · OD · contact PI
Mid-Atlantic Nutrition Obesity Research Center$1,066,877
P30 · FY2013 · DK · contact PI
Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy$612,577
R01 · FY2013 · NS
Mid-Atlantic Nutrition Obesity Research Center$265,963
P30 · FY2013 · DK · contact PI
Administrative Core$174,515
P30 · FY2013 · DK · contact PI
Research Base$121,018
P30 · FY2013 · DK · contact PI
Genomics Core$65,897
P30 · FY2013 · NR · contact PI
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$3,081,248
U01 · FY2012 · HL · contact PI
Mid-Atlantic Nutrition Obesity Research Center$1,133,261
P30 · FY2012 · DK · contact PI
Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy$671,934
R01 · FY2012 · NS
Administrative Core$187,793
P30 · FY2012 · DK · contact PI
Research Base$134,294
P30 · FY2012 · DK · contact PI
Genomics Core$69,511
P30 · FY2012 · NR · contact PI
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$2,293,673
U01 · FY2011 · HL · contact PI
Mid-Atlantic Nutrition Obesity Research Center$1,133,261
P30 · FY2011 · DK · contact PI
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$802,066
U01 · FY2011 · HL · contact PI
Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy$745,177
R01 · FY2011 · NS
Administrative Core$187,793
P30 · FY2011 · DK · contact PI
Research Base$134,294
P30 · FY2011 · DK · contact PI
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$2,341,982
U01 · FY2010 · HL · contact PI
Mid-Atlantic Nutrition Obesity Research Center$1,145,761
P30 · FY2010 · DK · contact PI
The Thrifty Microbiome: The Role of the Gut Microbiota in Obesity in the Amish$250,000
UH2 · FY2010 · DK
Administrative Core$215,388
P30 · FY2010 · DK · contact PI
Research Base$152,347
P30 · FY2010 · DK · contact PI
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study$73,825
U01 · FY2010 · HL · contact PI
Clinical Research Career Development (RMI)$3,440,743
K12 · FY2009 · RR · contact PI
Pharmacogenomics of CVD risk Reduction$1,494,237
U01 · FY2009 · GM · contact PI
Pharmacogenomics of Anti-platelet Agents for CVD Prevention$1,494,237
U01 · FY2009 · GM · contact PI
Clinical Nutrition Research Unit of Maryland$1,043,386
P30 · FY2009 · DK · contact PI
The Thrifty Microbiome: The Role of the Gut Microbiota in Obesity in the Amish$1,024,737
UH2 · FY2009 · DK
Genetics Core$390,837
P30 · FY2009 · DK · contact PI
Clinical Nutrition Research Unit of Maryland$297,736
P30 · FY2009 · DK · contact PI
Clinical Nutrition Research Unit of Maryland$126,500
P30 · FY2009 · DK · contact PI
Pharmacogenomics of CVD risk Reduction$123,825
U01 · FY2009 · GM · contact PI
Genetics of Diabetes in the Amish$115,388
R01 · FY2009 · DK · contact PI
Clinical Nutrition Research Unit of Maryland$54,360
P30 · FY2009 · DK · contact PI
Clinical Research Career Development (RMI)$2,778,583
K12 · FY2008 · RR · contact PI
Pharmacogenomics of CVD risk Reduction$1,450,714
U01 · FY2008 · GM · contact PI
Pharmacogenomics of Anti-platelet Agents for CVD Prevention$1,450,714
U01 · FY2008 · GM · contact PI
Clinical Nutrition Research Unit of Maryland$1,039,310
P30 · FY2008 · DK · contact PI
Genetics of Diabetes in the Amish$623,523
R01 · FY2008 · DK · contact PI
Genetics Core$363,915
P30 · FY2008 · DK · contact PI
Genome-wide Search for CVD Gene-Environment Interactions$344,654
U01 · FY2008 · HL · contact PI
Clinical Research Career Development (RMI)$3,437,533
K12 · FY2007 · RR · contact PI
Pharmacogenomics of CVD risk Reduction$1,450,524
U01 · FY2007 · GM · contact PI
Pharmacogenomics of Anti-platelet Agents for CVD Prevention$1,450,524
U01 · FY2007 · GM · contact PI
Genetics of Diabetes in the Amish$620,354
R01 · FY2007 · DK · contact PI
Genome-wide Search for CVD Gene-Environment Interactions$353,629
U01 · FY2007 · HL · contact PI
Genetics Core$215,223
P30 · FY2007 · DK · contact PI
Genetics of Diabetes in the Amish$74,250
R01 · FY2007 · DK · contact PI
Clinical Research Career Development (RMI)$2,088,366
K12 · FY2006 · RR · contact PI
Pharmacogenomics of Anti-platelet Agents for CVD Prevent$1,485,240
U01 · FY2006 · GM · contact PI
Pharmacogenomics of CVD risk Reduction$1,450,337
U01 · FY2006 · GM · contact PI
Genetics of Diabetes in the Amish$646,144
R01 · FY2006 · DK · contact PI
CORE--GENETICS, GENOMICS, AND GENETIC EPIDEMIOLOGY$226,806
P30 · FY2006 · DK · contact PI
Genetics of Diabetes in the Amish$74,250
R01 · FY2006 · DK · contact PI
PHARMACOGENETICS OF PRO 12ALA PPAR-GAMMA-2$5,942
M01 · FY2006 · RR · contact PI
Genome-wide Search for CVD Gene-Environment Interactions$2,440,104
U01 · FY2005 · HL
Clinical Research Career Development (RMI)$1,540,000
K12 · FY2005 · RR
Pharmacogenomics of Anti-platelet Agents for CVD Prevent$1,335,443
U01 · FY2005 · GM
Pharmacogenomics of CVD risk Reduction$1,335,443
U01 · FY2005 · GM
Longevity Genes in Founder Populations$745,409
R01 · FY2005 · AG
Genetics of Diabetes in the Amish$637,611
R01 · FY2005 · DK
GENOME WIDE RESEARCH FOR CVD GENE ENVIRONMENT INTERACTION$203,156
M01 · FY2005 · RR
CORE--GENETICS, GENOMICS, AND GENETIC EPIDEMIOLOGY$188,182
P30 · FY2005 · DK
Longevity Genes in Founder Populations$100,000
R01 · FY2005 · AG
PHARMACOGENETICS OF PRO 12ALA PPAR-GAMMA-2$31,108
M01 · FY2005 · RR
GENETICS OF DIABETES AND OBESITY$634
M01 · FY2005 · RR
Genome-wide Search for CVD Gene-Environment Interactions$2,897,961
U01 · FY2004 · HL
Longevity Genes in Founder Populations$769,423
R01 · FY2004 · AG
Genetics of Diabetes in the Amish$624,049
R01 · FY2004 · DK
GENETICS OF OSTEOPOROSIS IN THE AMISH$362,790
R01 · FY2004 · AR
Genetics of Longevity in the Amish$125,363
M01 · FY2004 · RR
GENETIC AND CLINICAL MANIFESTATIONS OF DIABETES$72,211
K24 · FY2004 · DK
Pharmacogenetics of PPAR - gamma$44,987
M01 · FY2004 · RR
Amish Family Osteoporosis Study$5,398
M01 · FY2004 · RR
Genetics of Diabetes and Obesity$1,799
M01 · FY2004 · RR
Genome-wide Search for CVD Gene-Environment Interactions$2,461,109
U01 · FY2003 · HL
Longevity Genes in Founder Populations$705,844
R01 · FY2003 · AG
GENETICS OF OSTEOPOROSIS IN THE AMISH$496,306
R01 · FY2003 · AR
GENETICS OF DIABETES IN THE AMISH$417,735
R01 · FY2003 · DK
GENETIC AND CLINICAL MANIFESTATIONS OF DIABETES$72,211
K24 · FY2003 · DK
Longevity Genes in Founder Populations$47,966
R01 · FY2003 · AG
Genome-wide Search for CVD Gene-Environment Interactions$2,752,310
U01 · FY2002 · HL
Longevity Genes in Founder Populations$686,927
R01 · FY2002 · AG
GENETICS OF OSTEOPOROSIS IN THE AMISH$654,378
R01 · FY2002 · AR
MALDI-TOF MS for High Throughput SNP Analysis$485,000
S10 · FY2002 · RR
PHARMACOGENETICS OF PRO12ALA PPAR GAMMA 2 IN DIABETES$429,739
R01 · FY2002 · DK
GENETICS OF DIABETES IN THE AMISH$405,512
R01 · FY2002 · DK
GENETIC AND CLINICAL MANIFESTATIONS OF DIABETES$72,211
K24 · FY2002 · DK
Longevity Genes in Founder Populations$7,177
R01 · FY2002 · AG
Longevity Genes in Founder Populations$691,758
R01 · FY2001 · AG
GENETICS OF OSTEOPOROSIS IN THE AMISH$576,842
R01 · FY2001 · AR
GENETICS OF DIABETES IN THE AMISH$424,239
R01 · FY2001 · DK
PHARMACOGENETICS OF PRO12ALA PPAR GAMMA 2 IN DIABETES$418,592
R01 · FY2001 · DK
GENETIC AND CLINICAL MANIFESTATIONS OF DIABETES$117,422
K24 · FY2001 · DK
GENETICS OF OSTEOPOROSIS IN THE AMISH$583,662
R01 · FY2000 · AR
GENETICS OF DIABETES IN THE AMISH$467,419
R01 · FY2000 · DK
PHARMACOGENETICS OF PRO12ALA PPAR GAMMA 2 IN DIABETES$407,769
R01 · FY2000 · DK
GENETIC AND CLINICAL MANIFESTATIONS OF DIABETES$117,422
K24 · FY2000 · DK
GENETICS OF TYPE II DIABETES MELLITUS AND OBESITY$0
M01 · FY2000 · RR
GENETICS OF TYPE II DIABETES MELLITUS AND OBESITY$0
M01 · FY2000 · RR
GENETICS OF TYPE II DIABETES MELLITUS AND OBESITY$0
M01 · FY2000 · RR